Gastric Cancer Diagnostic Procedure Market Outlook 2034
Coverage: Gastric Cancer Diagnostic Procedure Market covers analysis By Healthcare Provider (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics); Symptom Type (Symptomatic, Asymptomatic); Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue); Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays); and Geography
- Report Date : Apr 2026
- Report Code : TIPRE00029842
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The gastric cancer diagnostic procedure market size is expected to reach US$ 2.69 billion by 2034 from US$ 1.53 billion in 2025. The market is anticipated to register a CAGR of 6.53% during 2026–2034.
Gastric Cancer Diagnostic Procedure Market AnalysisThe Gastric Cancer Diagnostics market is experiencing rapid expansion due to the rising global incidence of gastric cancer. This growth is further fueled by the increasing emphasis on early detection and screening programs and significant advancements in diagnostic technologies. Technologies such as molecular diagnostics, advanced imaging, and non-invasive methods like liquid biopsy are becoming increasingly integral for personalized treatment plans. The market is shifting towards precision medicine, which relies heavily on advanced diagnostic tools to identify specific biomarkers (e.g., HER2, PD-L1) for targeted therapies. The market is expected to grow rapidly with the continuous development of novel biomarkers and the expansion of diagnostic services into specialized laboratories and hospitals.
Gastric Cancer Diagnostic Procedure Market OverviewThe implementation of advanced diagnostic procedures in gastric cancer is crucial for early detection, accurate staging, and guiding personalized therapeutic strategies. Procedures range from traditional methods like endoscopy with biopsy and imaging tests (CT, MRI) to advanced molecular diagnostics and liquid biopsies. These tools provide critical information on the tumor's genetic and molecular profile, allowing clinicians to tailor treatments for improved patient outcomes. The market is highly influenced by the high prevalence of Adenocarcinoma, the most common type of gastric cancer. There is a continuous drive to develop more cost-effective and non-invasive diagnostic solutions to improve patient access, especially in high-risk populations and developing regions.
Strategic InsightsGastric Cancer Diagnostic Procedure Market Drivers and OpportunitiesMarket Drivers:
- Increasing Global Incidence of Gastric Cancer: The rising prevalence of gastric cancer, often linked to an aging population, lifestyle factors (smoking, alcohol use), and Helicobacter pylori infection, is the primary driver for increased demand for diagnostic tools.
- Advancements in Diagnostic Technologies: Innovations like AI-powered endoscopy, liquid biopsy, and the integration of Next-Generation Sequencing (NGS) for molecular profiling are enhancing the accuracy and efficiency of detection.
- Growing Focus on Early Detection and Screening: Government and healthcare organizations worldwide are implementing screening programs, particularly in high-incidence areas, to detect gastric cancer at earlier, more treatable stages.
Market Opportunities:
- Growth in Personalized Medicine: The shift toward tailored treatment plans based on individual patient genetic and molecular profiles creates a massive opportunity for manufacturers of advanced biomarker tests and companion diagnostics (e.g., tests for HER2, PD-L1).
- Development of Non-Invasive Diagnostics: The push for non-invasive methods, such as liquid biopsies (using blood, urine, or saliva), offers a less painful and more scalable approach for screening and monitoring, opening new avenues for market entry.
- Expansion of Telemedicine Services: The growing adoption of telemedicine, particularly for follow-up and remote consultation, provides an opportunity to enhance access to diagnostic evaluations for patients in remote or underserved areas.
The Gastric Cancer Diagnostics Market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends.
By Healthcare Provider:
- Diagnostic Laboratories
- Hospitals
- Cancer Research Institutes
- Oncology Specialty Clinics
By Symptom Type:
- Symptomatic
- Asymptomatic
By Body Fluid:
- Blood
- Urine
- Saliva
- Stomach Wash/Gastric Juice
- Tissue
By Procedure:
- Endoscopic Procedures
- Biopsy & Tissue Tests
- Lab Tests
- In-Vitro Diagnostic Tests
- Imaging Tests
- Molecular Diagnostics
- Multiplexing Molecular Diagnostics & Immunoassays
By Geography:
- North America
- Europe
- Asia-Pacific
- South & Central America
- Middle East & Africa
North America holds the largest market share, driven by a robust and advanced healthcare infrastructure, high adoption of precision medicine, and the presence of key industry players. Asia-Pacific is anticipated to be the fastest-growing regional market due to the highest incidence rates of gastric cancer, a large and aging population, and improving healthcare investment.
North America
- Market Share: Holds the largest market share, driven by sophisticated healthcare systems and high technology adoption.
- Key Drivers: High adoption of advanced diagnostic technologies (liquid biopsy, NGS), presence of leading diagnostics companies, and a strong focus on personalized medicine.
- Trends: Increasing use of molecular profiling and companion diagnostics for targeted therapy selection.
Europe
- Market Share: Significant market share, supported by well-established healthcare systems.
- Key Drivers: Strong regulatory framework and public-private collaborations to improve cancer care.
- Trends: Focus on high-quality, standardized diagnostic practices and increasing investment in R&D for novel biomarkers.
Asia Pacific
- Market Share: The fastest-growing regional market, driven by high disease burden.
- Key Drivers: Highest incidence of gastric cancer globally, government-backed initiatives for cancer screening, and expanding healthcare infrastructure.
- Trends: Mass screening programs in high-risk areas and rapid adoption of advanced digital diagnostic tools.
South and Central America
- Market Share: Emerging region with growing adoption.
- Key Drivers: Increasing awareness of gastric cancer risk factors and improving digital infrastructure supporting diagnostic platforms.
- Trends: Expansion of affordable diagnostic solutions by global tech providers and rising digital adoption in healthcare.
Middle East and Africa
- Market Share: Emerging market with strong growth potential.
- Key Drivers: Major national digital transformation strategies in countries like the UAE and Saudi Arabia, and increasing investment in specialized cancer centers.
- Trends: Implementation of specialized diagnostic services and integration of basic molecular testing.
The Gastric Cancer Diagnostics Market is highly competitive, featuring established global pharmaceutical and diagnostics companies alongside specialized biotechnology firms and molecular diagnostics startups. Competition centers around innovation in achieving earlier, more accurate, and less invasive detection.
The competitive landscape is driving vendors to differentiate through:
- Developing cutting-edge technologies like AI for image analysis (endoscopy, pathology) and liquid biopsy assays to offer non-invasive and highly sensitive tests.
- Intense R&D efforts to discover and commercialize new biomarkers and the companion diagnostics required for targeted therapies.
- Collaborations between diagnostic companies and pharmaceutical firms to co-develop diagnostic tests alongside new cancer drugs, ensuring seamless patient selection for specific treatments.
Opportunities and Strategic Moves
- Personalized Diagnostics: Leveraging advanced genomic and proteomic platforms to provide a comprehensive profile of a patient’s tumor, opening new revenue streams through highly specialized, high-value testing.
- Mergers and Acquisitions (M&A): Large players acquire smaller biotech and diagnostics startups to quickly integrate novel technologies (like liquid biopsy or AI algorithms) into their existing portfolios.
- Global Expansion: Focusing on high-incidence regions, particularly Asia-Pacific, by establishing local distribution networks and obtaining regional regulatory approvals to capitalize on high demand.
- Atlas-Link Biotech Co Ltd
- Bio-Rad Laboratories Inc
- MiRXES Pte Ltd
- Agilent Technologies Inc
- F. Hoffmann-La Roche Ltd
- bioMerieux SA
- Thermo Fisher Scientific Inc
- Illumina Inc
- Vela Diagnostics Holding Pte Ltd
Disclaimer: The companies listed above are not ranked in any particular order.
Gastric Cancer Diagnostic Procedure Market News and Recent Developments- For instance, on October 09, 2025, Mirxes, a leading and only publicly-listed molecular cancer early detection company in Asia Pacific, announced that its flagship product, GASTROClear™, has been granted regulatory approval by China’s National Medical Products Administration (NMPA) as an in vitro diagnostic (IVD) product, becoming the first non-invasive blood test approved for the screening of gastric cancer in China.
- On April 17, 2025, Agilent Technologies Inc. announced its PD-L1 IHC 22C3 pharmDx assay has received European IVDR certification for use as a Companion Diagnostic (CDx) to aid in the identification of gastric or gastroesophageal Junction (GEJ) adenocarcinoma patients who may be eligible for treatment with KEYTRUDA® (pembrolizumab)1. PD-L1 IHC 22C3 pharmDx is approved for exclusive use with the Agilent Autostainer Link 48 advanced staining solution. KEYTRUDA is an anti-PD-1 therapy developed by Merck.
- In October 2024, Roche received FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY.
The "Gastric Cancer Diagnostics Procedure Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- Gastric Cancer Diagnostics Procedure Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Gastric Cancer Diagnostics Procedure Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Gastric Cancer Diagnostics Procedure Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Gastric Cancer Diagnostics Procedure Market. Detailed company profiles.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Healthcare Provider, Symptom Type, Body Fluid, Procedure, Offering, and Disease Indication
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The gastric cancer diagnostic procedure market consists mainly of the players, such as Atlas-Link Biotech Co Ltd, Bio-Rad Laboratories Inc, MiRXES Pte Ltd, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc, Illumina Inc, Vela Diagnostics Holding Pte Ltd, and Myriad Genetics Inc.
North America holds the largest market share due to its advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region due to the highest disease incidence and government-led screening programs.
The future trends include the increasing use of AI-driven diagnostic imaging, a shift toward non-invasive tests like liquid biopsy, and the expansion of molecular diagnostics for personalized medicine.
The major driving factors are the rising global incidence of gastric cancer, the growing emphasis on early detection and screening programs, and continuous advancements in diagnostic technologies.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For